J&J Could Explore Potential $2B Sale of Sterilization Products Division Post author:Sam Post published:February 19, 2018 Post category:BioPharma Life sciences giant Johnson & Johnson may be shopping around its sterilization products division. Source: BioSpace You Might Also Like SteadyMed Announces FDA Agreed Pathway to Trevyent NDA Resubmission December 7, 2017 Philadelphia Biotech Startup Context Therapeutics Names a New CFO, Effective Immediately November 15, 2017 Why These 3 Drugmakers Could Buy Incyte April 11, 2017
Philadelphia Biotech Startup Context Therapeutics Names a New CFO, Effective Immediately November 15, 2017